ArticleSage open pediatrics
Adherence to Nevirapine Prophylaxis and Its Predictors Among HIV-Exposed Infants Aged 0 to 6 months in Western Uganda: A Cross-Sectional Study.
Article in Sage open pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HIV remains a global public health issue; Uganda has nearly 7% of infants born to HIV positive mothers getting infected despite initiation on Nevirapine prophylaxis against HIV transmission among HIV-exposed infants. There is paucity of data regarding adherence to NVP in Western Uganda. This study aimed at assessing the predictors of adherence to nevirapine prophylaxis among HIV -exposed infants aged 0 to 6 months. A cross-sectional study was done among 200 HIV-exposed infants aged 0 to 6 months. Participants were consecutively recruited. Data was analyzed using SPSS version 26, logistic regression was used to infer predictors of Nevirapine adherence. Adherence to Nevirapine prophylaxis was at 95.0% (CI: 89-98). Factors associated with adherence included; disclosure of HIV status [aOR = 0.083; 95% CI: 0.007-0.92,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.